Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Naoya Hashimoto

ResearcherPublications, citations & collaboration network

Naoya Hashimoto is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 258 works, 6,288 citations, an h-index of 41 and an i10-index of 109.

258
Works
6,288
Citations
41
h-index
109
i10-index

How has Naoya Hashimoto's publication output changed over time?

ScholarIQpublication output · 2005–2018

Output grew0% over the shown period — from 1 works in 2005 to 1 in 2018.

1
4
1
1
1
2
1
2005200820112013201520162018

What are the most-cited papers on Naoya Hashimoto?

ScholarIQmost cited works
Immunotherapy response assessment in neuro-oncology: a report of the RANO working group
Hideho Okada, Michael Weller, Raymond Y. Huang, Gaetano Finocchiaro, Mark R. Gilbert, Wolfgang Wick, Benjamin M. Ellingson, Naoya Hashimoto, Ian F. Pollack, Alba A. Brandes, Enrico Franceschi, Christel Herold‐Mende, Lakshmi Nayak, Ashok Panigrahy, Whitney B. Pope, Robert M. Prins, John H. Sampson, Patrick Y. Wen, David A. Reardon
The Lancet Oncology. 2015772 CitationsOPEN ACCESS
Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis
Eric M. Thompson, Thomas Hielscher, Éric Bouffet, Marc Remke, Betty Luu, Sridharan Gururangan, Roger E. McLendon, Darell D. Bigner, Eric Lipp, Sébastien Perreault, Yoon-Jae Cho, Gerald A. Grant, Seung‐Ki Kim, Ji Yeoun Lee, Amulya A. Nageswara Rao, Caterina Giannini, Kay Ka Wai Li, Ho‐Keung Ng, Yu Yao, Toshihiro Kumabe, Teiji Tominaga, Wiesława Grajkowska, Marta Perek‐Polnik, David C.Y. Low, Wan Tew Seow, Kenneth Tou En Chang, Jaume Mora, Ian F. Pollack, Ronald L. Hamilton, Sarah Leary, Andrew S. Moore, Wendy J. Ingram, Andrew R. Hallahan, Anne Jouvet, Michelle Fèvre‐Montange, Alexandre Vasiljevic, Cécile Faure‐Conter, Tomoko Shofuda, Naoki Kagawa, Naoya Hashimoto, Nada Jabado, Alexander G. Weil, Tenzin Gayden, Takafumi Wataya, Tarek Shalaby, Michael A. Grotzer, Karel Zitterbart, Jaroslav Štěrba, Leoš Křen, Tibor Hortobágyi, Álmos Klekner, László Bognár, Tímea Pócza, Péter Hauser, Ulrich Schüller, Shin Jung, Woo‐Youl Jang, Pim J. French, Johan M. Kros, Marie‐Lise C. van Veelen, Luca Massimi, Jeffrey R. Leonard, Joshua B. Rubin, Rajeev Vibhakar, Lola B. Chambless, Michael K. Cooper, Reid C. Thompson, Cláudia C. Faria, Alice Carvalho, Sofia Nunes, José Pimentel, Xing Fan, Karin M. Muraszko, Enrique López‐Aguilar, David Lyden, Livia Garzia, David Shih, Noriyuki Kijima, Christian Schneider, Jennifer Adamski, Paul A. Northcott, Marcel Kool, David Jones, Jennifer A. Chan, Ana Nikolić, Maria Luisa Garrè, Erwin G. Van Meir, Satoru Osuka, Jeffrey J. Olson, Arman Jahangiri, Brandyn Castro, Nalin Gupta, William A. Weiss, Iska Moxon‐Emre, Donald Mabbott, Álvaro Lassaletta, Cynthia Hawkins, Uri Tabori, James M. Drake, Abhaya V. Kulkarni
The Lancet Oncology. 2016374 CitationsOPEN ACCESS
A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas
Hideyuki Arita, Kai Yamasaki, Yuko Matsushita, Taishi Nakamura, Asanao Shimokawa, Hirokazu Takami, Shota Tanaka, Akitake Mukasa, Mitsuaki Shirahata, Saki Shimizu, Kaori Suzuki, Kuniaki Saito, Keiichi Kobayashi, Fumi Higuchi, Takeo Uzuka, Ryohei Otani, Kaoru Tamura, Kazutaka Sumita, Makoto Ohno, Yasuji Miyakita, Naoki Kagawa, Naoya Hashimoto, Ryusuke Hatae, Koji Yoshimoto, Naoki Shinojima, Hideo Nakamura, Yonehiro Kanemura, Yoshiko Okita, Manabu Kinoshita, Kenichi Ishibashi, Tomoko Shofuda, Yoshinori Kodama, Kanji Mori, Yusuke Tomogane, Junya Fukai, Koji Fujita, Yuzo Terakawa, Naohiro Tsuyuguchi, Shusuke Moriuchi, Masahiro Nonaka, Hiroyoshi Suzuki, Makoto Shibuya, Taketoshi Maehara, Nobuhito Saito, Motoo Nagane, Nobutaka Kawahara, Keisuke Ueki, Toshiki Yoshimine, Etsuo Miyaoka, Ryo Nishikawa, Takashi Komori, Yoshitaka Narita, Koichi Ichimura
S2764650462. 2016266 CitationsOPEN ACCESS
Fiber-tracking does not accurately estimate size of fiber bundle in pathological condition: initial neurosurgical experience using neuronavigation and subcortical white matter stimulation
Manabu Kinoshita, Kei Yamada, Naoya Hashimoto, Amami Kato, Shuichi Izumoto, Takahito Baba, Motohiko Maruno, Tsunehiko Nishimura, Toshiki Yoshimine
NeuroImage. 2005265 Citations
Phase II clinical trial of Wilms tumor 1 peptide vaccination for patients with recurrent glioblastoma multiforme
Shuichi Izumoto, Akihiro Tsuboi, Yoshitaka Oka, Tsuyoshi Suzuki, Tetsuo Hashiba, Naoki Kagawa, Naoya Hashimoto, Motohiko Maruno, Olga A. Elisseeva, Toshiaki Shirakata, Manabu Kawakami, Yusuke Oji, Sumiyuki Nishida, Satoshi Ohno, Ichiro Kawase, Jun Hatazawa, Shin‐ichi Nakatsuka, Katsuyuki Aozasa, Satoshi Morita, Junichi Sakamoto, Haruo Sugiyama, Toshiki Yoshimine
Journal of neurosurgery. 2008214 Citations

Related on ScholarIQ

Kyoto Prefectural University
Institution
Immunotherapy response assessment in neuro-oncology: a report of the RANO working group
Paper
Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis
Paper
A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas
Paper
Fiber-tracking does not accurately estimate size of fiber bundle in pathological condition: initial neurosurgical experience using neuronavigation and subcortical white matter stimulation
Paper
Phase II clinical trial of Wilms tumor 1 peptide vaccination for patients with recurrent glioblastoma multiforme
Paper
470M+ articles · free account